Dr. Carmella Evans-Molina is the Eli Lilly Professor of Pediatric Diabetes at the Indiana University School of Medicine in Indianapolis, IN, where she serves as Director of the IU Center for Diabetes and Metabolic Diseases and Program Leader for the Diabetes Research Group in the Herman B Wells Center for Pediatric Research and as a Staff Physician at the Roudebush Veteran's Affairs (VA) Medical Center.  Her research centers on unraveling the molecular and signaling pathways operating within pancreatic β cells that drive the transition from a compensated state of euglycemia to a decompensated state of hyperglycemia in both type 1 (T1D) and type 2 diabetes (T2D).  In basic science work, Dr. Evans-Molina has pioneered the concept that alterations in calcium signaling within the β cell secretory pathway are linked with impairments in insulin secretion, processing, and trafficking and lead to the activation of organelle-specific stress pathways such as endoplasmic reticulum and Golgi stress.  Dr. Evans-Molina's translational and clinical projects harness knowledge gained from studying stress within the β cell to develop innovative biomarker strategies with the goal of informing T1D screening strategies and the identification of targets for disease-modifying therapies.  Her research is funded by the NIH, the VA Research Program, the JDRF, and the Helmsley Charitable Trust.  She is an investigator in the NIH-funded Type 1 Diabetes Trialnet, RADIANT, and TIDAPC/DREAM Networks.  Dr. Evans-Molina is a Co-Executive Director of the Network for Pancreatic Organ Donors with Diabetes (nPOD), Co-PI of the NIH-funded Integrated Islet Distribution Program, and President of the Immunology of Diabetes Society (IDS).